Correlation Between Summit Therapeutics and NYSE Declining
Can any of the company-specific risk be diversified away by investing in both Summit Therapeutics and NYSE Declining at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Summit Therapeutics and NYSE Declining into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Summit Therapeutics PLC and NYSE Declining Volume, you can compare the effects of market volatilities on Summit Therapeutics and NYSE Declining and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Summit Therapeutics with a short position of NYSE Declining. Check out your portfolio center. Please also check ongoing floating volatility patterns of Summit Therapeutics and NYSE Declining.
Diversification Opportunities for Summit Therapeutics and NYSE Declining
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Summit and NYSE is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and NYSE Declining Volume in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NYSE Declining Volume and Summit Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Summit Therapeutics PLC are associated (or correlated) with NYSE Declining. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NYSE Declining Volume has no effect on the direction of Summit Therapeutics i.e., Summit Therapeutics and NYSE Declining go up and down completely randomly.
Pair Corralation between Summit Therapeutics and NYSE Declining
Given the investment horizon of 90 days Summit Therapeutics PLC is expected to under-perform the NYSE Declining. But the stock apears to be less risky and, when comparing its historical volatility, Summit Therapeutics PLC is 17.54 times less risky than NYSE Declining. The stock trades about -0.01 of its potential returns per unit of risk. The NYSE Declining Volume is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 152,309 in NYSE Declining Volume on October 10, 2024 and sell it today you would earn a total of 16,520 from holding NYSE Declining Volume or generate 10.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.24% |
Values | Daily Returns |
Summit Therapeutics PLC vs. NYSE Declining Volume
Performance |
Timeline |
Summit Therapeutics and NYSE Declining Volatility Contrast
Predicted Return Density |
Returns |
Summit Therapeutics PLC
Pair trading matchups for Summit Therapeutics
NYSE Declining Volume
Pair trading matchups for NYSE Declining
Pair Trading with Summit Therapeutics and NYSE Declining
The main advantage of trading using opposite Summit Therapeutics and NYSE Declining positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Summit Therapeutics position performs unexpectedly, NYSE Declining can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NYSE Declining will offset losses from the drop in NYSE Declining's long position.Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
NYSE Declining vs. Genfit | NYSE Declining vs. Summit Therapeutics PLC | NYSE Declining vs. NETGEAR | NYSE Declining vs. Integral Ad Science |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |